● Recruiting

Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC

Condition: Lung Cancer · Sarcopenia · Toxicity · Sponsor: Instituto Nacional de Cancerologia de Mexico

PhaseN/A

Planned participants132

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This study evaluate the association of body composition (mainly free-fat mass), clinical and biochemical parameters with development of toxicity in patients under treatment with Carboplatin/Paclitaxel in advanced NSCLC.

This description comes directly from the study's public registry record.

Talk to the study team

Oscar Arrieta, MD, M Sc · 015556280400 · ogar@unam.mx

Always discuss trial participation with your own doctor first.

Locations (1)

Instituto Nacional de Cancerologia

Mexico City, Mexico

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02734069